VWM
Venturi Wealth Management Portfolio holdings
AUM
$2.02B
1-Year Return
18.03%
This Quarter Return
+10.52%
1 Year Return
+18.03%
3 Year Return
+66.13%
5 Year Return
+111.48%
10 Year Return
–
AUM
$1.42B
AUM Growth
+$144M
(+11%)
Cap. Flow
+$8.92M
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
38.97%
Holding
1,455
New
151
Increased
511
Reduced
341
Closed
106
Top Buys
| 1 |
Atlas Energy Solutions
AESI
|
+$28M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$19.2M |
| 3 |
Capital Group Municipal Income ETF
CGMU
|
+$14.7M |
| 4 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$13.4M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$13.1M |
Top Sells
| 1 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$20.6M |
| 2 |
iShares Core S&P US Value ETF
IUSV
|
+$15.9M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$14M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$13.6M |
| 5 |
iShares Russell 2000 Growth ETF
IWO
|
+$10.2M |
Sector Composition
| 1 | Technology | 13.82% |
| 2 | Financials | 4.79% |
| 3 | Consumer Discretionary | 4.52% |
| 4 | Healthcare | 4.35% |
| 5 | Industrials | 4.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Biogen
BIIB
$20.6B
| $17.9K | ﹤0.01% |
69
+4
| +6% | +$1.04K |
|
727
Heron Therapeutics
HRTX
$198M
| $17.9K | ﹤0.01% |
10,500
| – | – |
|
728
First American
FAF
$6.68B
| $17.9K | ﹤0.01% |
277
+149
| +116% | +$9.6K |
|
729
CCC Intelligent Solutions
CCCS
$6.19B
| $17.8K | ﹤0.01% |
+1,566
| New | +$17.8K |
|
730
Entegris
ENTG
$12B
| $17.7K | ﹤0.01% |
148
| – | – |
|
731
Tyler Technologies
TYL
$23.6B
| $17.6K | ﹤0.01% |
42
| – | – |
|
732
EPAM Systems
EPAM
$8.7B
| $17.5K | ﹤0.01% |
59
+16
| +37% | +$4.76K |
|
733
Vertiv
VRT
$53.2B
| $17.5K | ﹤0.01% |
365
+143
| +64% | +$6.87K |
|
|
MRO
734
DELISTED
Marathon Oil Corporation
MRO
| $17.5K | ﹤0.01% |
724
+22
| +3% | +$532 |
|
735
Fair Isaac
FICO
$37.1B
| $17.5K | ﹤0.01% |
15
-2
| -12% | -$2.33K |
|
736
Cognizant
CTSH
$33.8B
| $17.4K | ﹤0.01% |
231
+113
| +96% | +$8.54K |
|
737
Tarsus Pharmaceuticals
TARS
$2.33B
| $17.4K | ﹤0.01% |
861
| – | – |
|
738
Moody's
MCO
$90.7B
| $17.2K | ﹤0.01% |
44
+10
| +29% | +$3.91K |
|
739
Entergy
ETR
$39.2B
| $17.1K | ﹤0.01% |
338
+126
| +59% | +$6.38K |
|
740
Jabil
JBL
$23B
| $17.1K | ﹤0.01% |
134
+3
| +2% | +$382 |
|
741
Bright Horizons
BFAM
$6.42B
| $17.1K | ﹤0.01% |
181
| – | – |
|
|
AZEK
742
DELISTED
The AZEK Co
AZEK
| $17K | ﹤0.01% |
445
+256
| +135% | +$9.79K |
|
743
Masco
MAS
$15.3B
| $17K | ﹤0.01% |
254
-72
| -22% | -$4.82K |
|
744
DexCom
DXCM
$29.9B
| $17K | ﹤0.01% |
137
+46
| +51% | +$5.71K |
|
745
Carter's
CRI
$1.05B
| $16.9K | ﹤0.01% |
226
| – | – |
|
746
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$30.1B
| $16.9K | ﹤0.01% |
338
+148
| +78% | +$7.39K |
|
747
Catalyst Pharmaceutical
CPRX
$2.44B
| $16.8K | ﹤0.01% |
1,000
| – | – |
|
748
Inspire 100 ETF
BIBL
$327M
| $16.8K | ﹤0.01% |
+480
| New | +$16.8K |
|
749
FirstEnergy
FE
$24.8B
| $16.6K | ﹤0.01% |
454
| – | – |
|
750
Olin
OLN
$2.92B
| $16.6K | ﹤0.01% |
308
+169
| +122% | +$9.12K |
|